ALSO NOTED: Bayer ups Schering bid; Antibiotic may work against serious asthma attack; and much more...

Bayer slightly upped its official bid for Germany's Schering, offering $20.01 billion. Schering's board has recommended the offer. Report

Researchers say the antibiotic telithromycin, usually used to treat sinusitis, may also help people deal with serious asthma attacks. Report

Pharmacopeia Drug Discovery will gain a milestone on Schering-Plough's decision to develop one of its compounds for respiratory illness. Report

Fisher Scientific International is buying Clintrak Pharmaceutical Services for $125 million. Clintrak provides clinical trial printing services. Report

Edinburgh-based Ardana says that its cream for testosterone deficiency passed a mid-stage trial with 42 patients. Article

Novacea has launched a Phase III trial for its cancer therapy DN-101. Release

Chutes & Ladders: ArQule CFO Louise Mahoney is leaving, but plans to stay on until her successor has been named. Report

And Finally… A British court ruling may clear the way for hundreds of women to obtain the breast-cancer therapy Herceptin. Article